A pilot study of myeloablative (MA) autologous stem cell (autoSCT) followed by reduced intensity (RI) allogeneic transplantation (AlloSCT) in children and adolescents with relapsed hodgkin’s disease (HD) and non-hodgkin’s lymphoma (NHL)
Authors:
Open Access
- 1 February 2006
- journal article
- abstracts
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 12 (2) , 115-116